ArticleCell communication and signaling : CCS2025

Identification of genetically engineered strategies to manipulate nano-platforms presenting immunotherapeutic ligands for alleviating primary ovarian insufficiency progression.

Guannan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.